Pharvaris (PHVS) Non Operating Income (2021 - 2026)

Pharvaris (PHVS) posted Non Operating Income of $6.3 million for Q1 2026, down 100.0% on a QoQ basis from $6925.9 billion in Q3 2025, and up 254.43% year-over-year from $1.8 million in Q1 2025.

Pharvaris (PHVS) Non Operating Income (2021 - 2026) Analysis & Trends

Pharvaris' Non Operating Income history runs 6 years deep, the most recent figure standing at $6.3 million for Q1 2026.

  • Quarterly Non Operating Income rose 254.43% year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10749.8 billion (up 10239.67% YoY) and the FY2025 annual result came in at -$4.4 million, down 130.54% from the prior year.
  • Non Operating Income was $6.3 million for Q1 2026 at Pharvaris, down from $6925.9 billion in the prior quarter.
  • Across five years, Non Operating Income topped out at $6925.9 billion in Q3 2025 and bottomed at -$3929.9 billion in Q3 2024.
  • A 5-year average of $454.7 billion and a median of $3.0 million in 2023 frame the typical range for Non Operating Income.
  • Peak annual rise in Non Operating Income reached 168404778.33% in 2024, while the deepest fall reached 131324989.28% in 2024.
  • Pharvaris' Non Operating Income stood at -$26.9 million in 2022, then jumped by 91.55% to -$2.3 million in 2023, then soared by 168404778.33% to $3823.8 billion in 2024, then jumped by 81.12% to $6925.9 billion in 2025, then slumped by 100.0% to $6.3 million in 2026.
  • Business Quant data shows PHVS's Non Operating Income at $6.3 million in Q1 2026, $6925.9 billion in Q3 2025, and -$4.1 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -9.22 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 444,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 5.75 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -8.59 Mn
10 Pharvaris 2.22 Bn 1.94 Bn - 6.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.26 Mn
Sep 30, 2025 6,925.94 Bn
Mar 31, 2025 -4.05 Mn
Dec 31, 2024 3,823.84 Bn
Sep 30, 2024 -3,929.86 Bn
Jun 30, 2024 5.08 Mn
Mar 31, 2024 628,156.10
Dec 31, 2023 -2.27 Mn
Sep 30, 2023 2.99 Mn
Jun 30, 2023 709,619.36
Mar 31, 2023 -1.60 Mn
Dec 31, 2022 -26.88 Mn
Sep 30, 2022 11.59 Mn
Jun 30, 2022 12.27 Mn
Mar 31, 2022 3.81 Mn
Dec 31, 2021 -8,692.92 Bn
Sep 30, 2021 5.02 Mn
Jun 30, 2021 -2.98 Mn
Mar 31, 2021 7.02 Mn